Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C DeCaria

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Clinical Psychopharmacology|June 1, 1990
Treatment of depersonalization with serotonin reuptake blockersE Hollander, M R Liebowitz, C DeCaria, et al.
Psychosomatics|January 1, 1990
On dysmorphophobia misdiagnosed as obsessive-compulsive disorderE Hollander, D Neville, C DeCaria, et al.
Psychosomatics|January 1, 1992
Fluoxetine and depersonalization syndromeE Hollander, L Cohen, C DeCaria, et al.
Psychosomatics|March 1, 1993
Clinical and research issues in depersonalization syndromeE Hollander, M Y Hwang, L S Mullen, et al.
Psychopharmacology Bulletin|January 1, 1997
A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive ScaleK A Phillips, E Hollander, S A Rasmussen, et al.
Psychiatry Research|May 16, 2000
Increased growth hormone response to sumatriptan challenge in adult autistic disordersS Novotny, E Hollander, A Allen, et al.
Psychiatry Research|August 15, 1998
Serotonergic function in social phobia: comparison to normal control and obsessive-compulsive disorder subjectsE Hollander, J Kwon, F Weiller, et al.
Psychiatry Research|May 1, 1991
Noradrenergic function in obsessive-compulsive disorder: behavioral and neuroendocrine responses to clonidine and comparison to healthy controlsE Hollander, C DeCaria, A Nitescu, et al.
Psychiatry Research|September 29, 1995
Induction of depersonalization by the serotonin agonist meta-chlorophenylpiperazineD Simeon, E Hollander, D J Stein, et al.
Psychiatry Research|January 1, 1991
Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorderE Hollander, C DeCaria, R Gully, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Clinical Psychopharmacology|June 1, 1990
Treatment of depersonalization with serotonin reuptake blockersE Hollander, M R Liebowitz, C DeCaria, et al.
Psychosomatics|January 1, 1990
On dysmorphophobia misdiagnosed as obsessive-compulsive disorderE Hollander, D Neville, C DeCaria, et al.
Psychosomatics|January 1, 1992
Fluoxetine and depersonalization syndromeE Hollander, L Cohen, C DeCaria, et al.
Psychosomatics|March 1, 1993
Clinical and research issues in depersonalization syndromeE Hollander, M Y Hwang, L S Mullen, et al.
Psychopharmacology Bulletin|January 1, 1997
A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive ScaleK A Phillips, E Hollander, S A Rasmussen, et al.
Psychiatry Research|May 16, 2000
Increased growth hormone response to sumatriptan challenge in adult autistic disordersS Novotny, E Hollander, A Allen, et al.
Psychiatry Research|August 15, 1998
Serotonergic function in social phobia: comparison to normal control and obsessive-compulsive disorder subjectsE Hollander, J Kwon, F Weiller, et al.
Psychiatry Research|May 1, 1991
Noradrenergic function in obsessive-compulsive disorder: behavioral and neuroendocrine responses to clonidine and comparison to healthy controlsE Hollander, C DeCaria, A Nitescu, et al.
Psychiatry Research|September 29, 1995
Induction of depersonalization by the serotonin agonist meta-chlorophenylpiperazineD Simeon, E Hollander, D J Stein, et al.
Psychiatry Research|January 1, 1991
Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorderE Hollander, C DeCaria, R Gully, et al.
Pageof 3